COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE | N210455 | JANSSEN PRODUCTS LP
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Gilead Sciences, Inc. et al v. Apotex Inc. et al 5 patentsANDA 217728darunavir, cobicistat, emtricitabine, and tenofovir alafenamide | D. Del. | 2022-10-25 | Terminated 2025-02-18 | — |
Gilead Sciences, Inc. v. Apotex Inc. et al 2 patentsANDA 217728Tenofovir alafenamide (TAF) | D. Del. | 2022-10-25 | Terminated 2023-08-21 | — |
Gilead Sciences, Inc. et al v. Lupin Limited et al 4 patentsANDA 216511darunavir, cobicistat, emtricitabine, and tenofovir alafenamide (four-drug combination) | D. Del. | 2021-11-16 | Terminated 2025-02-18 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).